FDA Purchases XPS License — Developed by RCPE and Distributed by InSilicoTrials — as In-House Simulation Tool

Press release · RCPE / InSilicoTrials

The FDA has acquired an XPS simulation license for internal use, directly validating InSilicoTrials' regulatory-grade computational tools for pharmaceutical manufacturing.